# EDGAR Filing Document

**Accession Number:** 0000924628
**File Stem:** 0000910472-25-002614
**Filing Date:** 2025-10
**Character Count:** 13575
**Document Hash:** 90acb32c23f029bafedabb72cb6652d2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000910472-25-002614.hdr.sgml**: 20251029

**ACCESSION NUMBER**: 0000910472-25-002614

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250831

**FILED AS OF DATE**: 20251029

**DATE AS OF CHANGE**: 20251029

**PERIOD START**: 20250831

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SARATOGA ADVANTAGE TRUST
- **CENTRAL INDEX KEY:** 0000924628

**ORGANIZATION NAME:**
- **EIN:** 137044280
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0831

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08542
- **FILM NUMBER:** 251429443

**BUSINESS ADDRESS:**
- **STREET 1:** 1616 N LITCHFIELD RD.
- **STREET 2:** SUITE 165
- **CITY:** GOODYEAR
- **STATE:** AZ
- **ZIP:** 85395
- **BUSINESS PHONE:** 623-266-4567

**MAIL ADDRESS:**
- **STREET 1:** 1616 N LITCHFIELD RD.
- **STREET 2:** SUITE 165
- **CITY:** GOODYEAR
- **STATE:** AZ
- **ZIP:** 85395

## Series and Classes Contracts Data

### Health & Biotechnology Portfolio (Series ID: S000010884)

| Class ID   | Class Name                               | Ticker Symbol   |
|:---|:---|:---|
| C000030151 | Health & Biotechnology Portfolio Class I | SBHIX           |
| C000030153 | Health & Biotechnology Porfolio Class C  | SHPCX           |
| C000030154 | Health & Biotechnology Portfolio Class A | SHPAX           |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** SARATOGA ADVANTAGE TRUST

- **b. Investment Company Act file number:** 811-08542

- **c. CIK number of Registrant:** 0000924628

- **d. LEI of Registrant:** 549300ELDSPPW4ZGNR88

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 12725 W. Indian School Road

  - **City:** AVONDALE

  - **State:** AZ

  - **Foreign country:** US

  - **Zip / Postal Code:** 85392

  - **Telephone number:** 623-266-4567

**Item A.2. Information about the Series.**

- **a. Name of Series:** Saratoga Health & Biotechnology Fund

- **b. EDGAR series identifier (if any):** S000010884

- **c. LEI of Series:** 549300OYXRTQUB32LX72

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-08-31

- **b. Date as of which information is reported:** 2025-08-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $9905252.12

**Total Liabilities:** $53175.97

**Net Assets:** $9852076.15

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000030153 | 1.57%                | -4.11%               | 3.23%                |
| Class ID C000030151 | 1.71%                | -4.09%               | 3.32%                |
| Class ID C000030154 | 1.69%                | -4.15%               | 3.30%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $2.01                    | $178506.46                                 |
| Month 2  | $-74497.53               | $-315028.59                                |
| Month 3  | $-116804.68              | $447232.89                                 |

### Schedule of Portfolio Investments

| Name                                         | Title                              | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   | Fair Value Level   | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Medpace Holdings Inc.                        | MEDPACE HOLDINGS                   | CUSIP: 58506Q109<br>LEI: 549300H8TYEUVTW14A54 | Long             | EC               | CORP              | US        |       790 | NS      | $375652.90    | 3.81%             |  |  |  | No            | 1                  | On Loan: No      |
| Regeneron Pharmaceuticals, Inc.              | REGENERON PHARM                    | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |       670 | NS      | $389069.00    | 3.95%             |  |  |  | No            | 1                  | On Loan: No      |
| Mckesson Corp.                               | MCKESSON CORP                      | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |       806 | NS      | $553431.84    | 5.62%             |  |  |  | No            | 1                  | On Loan: No      |
| Eli Lilly & Co.                              | ELI LILLY & CO                     | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |       200 | NS      | $146516.00    | 1.49%             |  |  |  | No            | 1                  | On Loan: No      |
| Amgen Inc.                                   | AMGEN INC                          | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |      1992 | NS      | $573118.32    | 5.82%             |  |  |  | No            | 1                  | On Loan: No      |
| Exelixis, Inc.                               | EXELIXIS INC                       | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |     12368 | NS      | $462810.56    | 4.70%             |  |  |  | No            | 1                  | On Loan: No      |
| Novartis AG                                  | NOVARTIS AG-ADR                    | CUSIP: 66987V109<br>LEI: 5493007HIVTX6SY6XD66 | Long             | EC               | CORP              | CH        |      3740 | NS      | $473297.00    | 4.80%             |  |  |  | No            | 1                  | On Loan: No      |
| Johnson & Johnson                            | JOHNSON&JOHNSON                    | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |      1820 | NS      | $322449.40    | 3.27%             |  |  |  | No            | 1                  | On Loan: No      |
| Dreyfus Instl Resv                           | DREYFUS-INS-IS                     | CUSIP: 26200X100<br>LEI: 549300FG0OZ5YKPLK622 | Long             | STIV             | RF                | US        |    435116 | PA      | $435116.27    | 4.42%             |  |  |  | No            | 1                  | On Loan: No      |
| United Therapeutics Corporation              | UNITED THERAPEUT                   | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |      1400 | NS      | $426664.00    | 4.33%             |  |  |  | No            | 1                  | On Loan: No      |
| Merck & Co., Inc                             | MERCK & CO                         | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |      3206 | NS      | $269688.72    | 2.74%             |  |  |  | No            | 1                  | On Loan: No      |
| Intuitive Surgical Inc.                      | INTUITIVE SURGIC                   | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |       775 | NS      | $366803.63    | 3.72%             |  |  |  | No            | 1                  | On Loan: No      |
| Thermo Fisher Scientific Inc                 | THERMO FISHER                      | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |       708 | NS      | $348845.76    | 3.54%             |  |  |  | No            | 1                  | On Loan: No      |
| Labcorp Holdings Inc                         | LABCORP HOLDINGS                   | CUSIP: 504922105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1060 | NS      | $294669.40    | 2.99%             |  |  |  | No            | 1                  | On Loan: No      |
| DREYFUS TREASURY OBLIGATIONS CASH MANAGEMENT | DREYFUS TREASURY OBLIGATIONS #0521 | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             |  | US        |         0 | NS      | $0.00         | 0.00%             |  |  |  | No            | N/A                | On Loan: No      |
| Incyte Corporation.                          | INCYTE CORP                        | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |      3132 | NS      | $264998.52    | 2.69%             |  |  |  | No            | 1                  | On Loan: No      |
| Stryker Corporation                          | STRYKER CORP                       | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |       825 | NS      | $322913.25    | 3.28%             |  |  |  | No            | 1                  | On Loan: No      |
| IQVIA Holdings Inc.                          | IQVIA HOLDINGS I                   | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |      1050 | NS      | $200350.50    | 2.03%             |  |  |  | No            | 1                  | On Loan: No      |
| Cardinal Health, Inc.                        | CARDINAL HEALTH                    | CUSIP: 14149Y108<br>LEI: CCU46N3GJMF4OK4N7U60 | Long             | EC               | CORP              | US        |      3429 | NS      | $510166.62    | 5.18%             |  |  |  | No            | 1                  | On Loan: No      |
| Ensign Group Inc                             | ENSIGN GROUP INC                   | CUSIP: 29358P101<br>LEI: 5493003K4HEEA8Q0BC72 | Long             | EC               | CORP              | US        |      1499 | NS      | $257498.22    | 2.61%             |  |  |  | No            | 1                  | On Loan: No      |
| Medtronic PLC                                | MEDTRONIC PLC                      | CUSIP: G5960L103<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |      3126 | NS      | $290124.06    | 2.94%             |  |  |  | No            | 1                  | On Loan: No      |
| Elevance Health Inc.                         | ELEVANCE HEALTH                    | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |       433 | NS      | $137975.45    | 1.40%             |  |  |  | No            | 1                  | On Loan: No      |
| The Cigna Group                              | THE CIGNA GROUP                    | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |      1371 | NS      | $412492.77    | 4.19%             |  |  |  | No            | 1                  | On Loan: No      |
| Cencora Inc                                  | CENCORA INC                        | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |      1913 | NS      | $557849.93    | 5.66%             |  |  |  | No            | 1                  | On Loan: No      |
| Jazz Pharmaceuticals PLC                     | JAZZ PHARMACEUTI                   | CUSIP: G50871105<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |      3241 | NS      | $414037.75    | 4.20%             |  |  |  | No            | 1                  | On Loan: No      |
| National Healthcare Corporation              | NATL HEALTHCARE                    | CUSIP: 635906100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2112 | NS      | $239669.76    | 2.43%             |  |  |  | No            | 1                  | On Loan: No      |
| Gilead Sciences Inc.                         | GILEAD SCIENCES                    | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |      3068 | NS      | $346591.96    | 3.52%             |  |  |  | No            | 1                  | On Loan: No      |
| Vertex Pharmaceuticals Incorporated          | VERTEX PHARM                       | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |       787 | NS      | $307732.74    | 3.12%             |  |  |  | No            | 1                  | On Loan: No      |
| Davita Inc                                   | DAVITA INC                         | CUSIP: 23918K108<br>LEI: M2XHYMU3TZNEZURC6H66 | Long             | EC               | CORP              | US        |      1399 | NS      | $192726.24    | 1.96%             |  |  |  | No            | 1                  | On Loan: No      |

### Signature

**Date Signed:** 2025-09-26

**Name of Applicant:** SARATOGA ADVANTAGE TRUST

**Signature:** Rich Gleason

**Name of Signer:** Rich Gleason

**Title:** Assistant Treasurer